Ga-DOTATATE

gallium-68 DOTATATE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ga-DOTATATE, covering 2025-04-30 to 2025-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia [Phase 1, Phase 2]

See pricing